Search

Displaying results 51 - 58 of 58 in total
  1. Indication

    Metastatic Melanoma

    go.drugbank.com/conditions/DBCOND0030058
    Drugs: Aldesleukin · Atezolizumab · Binimetinib · Cobimetinib · Dabrafenib · Dacarbazine +13 more
  2. Indication

    Relapsed Multiple Myeloma

    go.drugbank.com/conditions/DBCOND0031510
    Drugs: Belantamab mafodotin · Carfilzomib · Ciltacabtagene autoleucel · Daratumumab · Dexamethasone · Elranatamab +8 more
  3. Indication

    Refractory Multiple Myeloma

    go.drugbank.com/conditions/DBCOND0028542
    Drugs: Belantamab mafodotin · Carfilzomib · Carmustine · Ciltacabtagene autoleucel · Daratumumab · Dexamethasone +11 more
  4. Indication

    Metastatic Colorectal Cancer (CRC)

    go.drugbank.com/conditions/DBCOND0134580
    Drugs: Aflibercept · Bevacizumab · Cetuximab · Encorafenib · Fluorouracil · Fruquintinib +12 more
  5. Drug

    Atezolizumab

    go.drugbank.com/drugs/DB11595
    ApprovedInvestigational

    Atezolizumab is a programmed death-ligand 1 (PD-L1) blocking antibody indicated for non-small cell lung cancer, small cell lung cancer, hepatocellular carcinoma, melanoma, alveolar soft part sarcoma, muscle invasive bladder cancer and co...

  6. Indication

    Multiple Myeloma

    go.drugbank.com/conditions/DBCOND0028259
    Drugs: Bortezomib · Chymotrypsin · Ciltacabtagene autoleucel · Cyclophosphamide · Daratumumab · Dexamethasone +16 more
  7. Indication

    Metastatic Breast Cancer

    go.drugbank.com/conditions/DBCOND0030200
    Drugs: Anastrozole · Bevacizumab · Carboplatin · Conjugated estrogens · Docetaxel · Doxorubicin +17 more
  8. Indication

    Metastatic Non-Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0043377
    Drugs: Adagrasib · Afatinib · Amivantamab · Atezolizumab · Binimetinib · Brigatinib +32 more